バイオ医薬品市場向け凍結乾燥サービス - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00009286
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 156
Buy Now

[調査レポート] バイオ医薬品市場向け凍結乾燥サービスは、2022 年の 20 億 5,141 万米ドルから 2028 年までに 35 億 8,655 万米ドルに成長すると予想されています。 2023 年から 2028 年にかけて 9.9% の CAGR が記録されると推定されています。

バイオ医薬品市場の成長のための凍結乾燥サービスは、凍結乾燥製品の需要の高まりと、世界中で急速に成長している受託製造および凍結乾燥サービスに起因すると考えられます。 .

バイオ医薬品市場向けの凍結乾燥サービスは、サービスの種類、エンドユーザー、地域に基づいて分割されています。このレポートは、バイオ医薬品市場の傾向、技術の進歩、市場のダイナミクス、主要な市場プレーヤーの競争状況分析のための凍結乾燥サービスなどのパラメーターに重点を置き、市場の洞察と詳細な分析を提供します。   

バイオ医薬品市場向け凍結乾燥サービス –戦略的洞察 

バイオ医薬品市場向けグローバル 凍結乾燥サービス 

バイオ医薬品市場向け凍結乾燥サービス –市場分析      

受託製造と凍結乾燥サービスの急増により、バイオ医薬品市場の成長を促進する凍結乾燥サービス

バイオ医薬品市場は世界中で拡大し続けています。製薬業界の主な成長原動力となる可能性があります。より多くの治療用生物製剤が承認されるにつれて、バイオ医薬品の非経口製造は最近拡大しています。バイオテクノロジー企業は、充填および仕上げのニーズを満たし、微生物汚染のリスクを軽減するために、受託製造組織 (CMO) から委託しています。バイオ医薬品企業は、必要に応じて生産能力や能力を提供する受託製造組織 (CMO) に依存しています。場合によっては、CMO が企業の生産の大部分を提供しています。

社内で凍結乾燥機能と操作をセットアップするには、特殊な機器と専門知識が必要であり、費用がかかります。時間がかかる。ただし、アウトソーシングの方がコストが安くなり、製造プロセスの効率が向上します。さらに、バイオテクノロジー企業はリソースを他の分野に振り向けることができます。したがって、医薬品開発者やバイオ医薬品会社は、全体の生産コストと収量コストを節約するために、そのような業務を CMO に委託します。数年前、CMO 業界はバイオテクノロジー企業に追加の製造能力や特定のサービスを提供するニッチなサービス市場でした。現在、多くのバイオテクノロジー企業が、初期段階の医薬品開発から商業規模の製造に至るまで、さまざまなサービスをアウトソーシングしています。バイオテクノロジー業界が大規模生産からニッチな標的療法(個別化医療)に移行するにつれ、柔軟な運用能力、生産規模、複数製品の運用に対する需要が高まっています。これらすべての要因により、CMO への傾向は高まっています。凍結乾燥操作のための特殊な施設と専用ラインを提供する CMO の 1 つが、Jubilant HollisterStier Contract Manufacturing & Ltd. です。サービス。 CMO は、市販の無菌注射剤と一連の凍結乾燥サービスを通じて、フェーズ I の無菌充填/仕上げを提供します。サービスに対する需要の高まりに対応するため、Jubilant は新しい 385 平方フィートの凍結乾燥機を設置しています。したがって、バイオ医薬品 CMO の能力と可用性の向上により、バイオ医薬品市場の成長のための凍結乾燥サービスが促進されます。

バイオ医薬品市場向けの世界の凍結乾燥サービス、サービス タイプ別 – 2022 年 vs 2028 年

バイオ医薬品市場向け凍結乾燥サービス –サービス タイプ別の洞察

サービス タイプに基づいて、バイオ医薬品市場向けの世界の凍結乾燥サービスは、商業製造、凍結乾燥サイクル開発、臨床製造、および凍結乾燥分析サービスに分類されます。商用製造セグメントは、2022 年に最大の市場シェアを保持しました。凍結乾燥サイクル開発セグメントは、予測期間中に最高の CAGR を記録すると予想されます。

バイオ医薬品市場向け凍結乾燥サービス –エンドユーザーベースの洞察

エンドユーザーに基づいて、バイオ医薬品市場向けの世界の凍結乾燥サービスは、製薬会社、バイオテクノロジー企業、研究機関などに分類されます。製薬およびバイオテクノロジー企業セグメントが 2022 年に最大の市場シェアを占めました。研究機関セグメントは、予測期間中に最高の CAGR を記録すると予想されます。 

バイオ医薬品市場向けの凍結乾燥サービスの企業は、無機およびバイオ医薬品市場向けの凍結乾燥サービスを採用しています。合併や買収などの有機的な戦略。最近の主要な市場動向を以下に示します。

  • 2022 年 11 月、LTI は結核ワクチン候補 ID93 / GLA-SE の開発、プロセスエンジニアリング、臨床材料の調製への取り組みを発表しました。 。結核ワクチンは第 2 相臨床試験に成功しました。この研究は、エマルジョンベースのアジュバントを含む熱安定性サブユニットワクチン候補の凍結乾燥の成功に関する最初の報告となる。
  • 2022 年 5 月、Jubilant HollisterStier LLC は陸軍請負業者と 1 億 4,960 万米ドルで協力協定を締結した。司令部は、米国保健福祉省内の生物医学先端研究開発局 (BARDA) を代表して、化学、生物、放射線、核防衛のための共同計画事務局 (JPEOCBRND) と連携して行う。
  • 2021 年 10 月、PCI ファーマ サービス (PCI) は、ベッドフォードに本社を置く主要な受託開発製造組織 (CDMO) である New England, Inc. (LSNE) の凍結乾燥サービスを買収する最終契約に署名したと発表しました。 , ニューハンプシャー州、世界的なプライベートエクイティ会社ペルミラ出身。この買収により、米国(ニューハンプシャー、ウィスコンシン)と欧州(スペイン)にFDA承認施設が5か所追加され、6か所目は今後数カ月以内に承認される予定だ。さらに、さらに 3 つの施設が開発中です。これらの施設により、世界的な 30 拠点のネットワークが強化されます。
  • 2021 年 7 月、Albany Molecular Research, Inc. (AMRI) は、2021 年 7 月 12 日付けで社名を Curia に変更すると発表しました。エンドツーエンドのグローバル CDMO としての同社の戦略的地位を強化し、その科学的専門知識と研究開発 (R&D) から商業生産までの広範な能力を応用して、製薬およびバイオテクノロジーの顧客が改善をもたらす重要な新製品を推進できるようにします。生きています。     

会社概要 - バイオ医薬品市場向け凍結乾燥サービス

  • ATTWILL Medical Solutions
  • Axcellerate Pharma LLC
  • Labyrinth Biopharma LLC
  • Berkshire Sterile Manufacturing
  • PCI Pharma Services
  • Curia Global Inc
  • Emergent BioSolutions Inc
  • Jubilant HollisterStier LLC
  • Biofortuna
  • Lyophilization Technology Inc.
  • SYNERLAB グループ
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the lyophilization services for biopharmaceuticals market?

Companies operating in the market are ATTWILL Medical Solutions; Axcellerate Pharma LLC; Labyrinth Biopharma LLC; Berkshire Sterile Manufacturing; PCI Pharma Services; Curia Global Inc; Emergent BioSolutions Inc.; Jubilant HollisterStier LLC; Biofortuna; Lyophilization Technology Inc.; and SYNERLAB GROUP.

What is lyophilization?

Lyophilization is a process of isolating a solid substance from a solution. It is also known as freeze-drying is a process. The process is carried by freezing the solution and evaporating under vacuum. It helps in optimizing lyophilization cycle times and improves stability for critically complexes of injectable during the parenteral product development.

What is the regional market scenario of the lyophilization services for biopharmaceuticals market?

Global lyophilization services for biopharmaceuticals market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the lyophilization services for biopharmaceuticals market during 2023–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving factors for the lyophilization services for biopharmaceuticals market across the globe?

The growth of market is likely to grow due to factors such as rising demand for lyophilized products and rapid growth in contract manufacturing and lyophilization services across the world are expected to boost the growth of the global lyophilization service for biopharmaceuticals market. However, the market is likely to get impacted by the demerits associated with lyophilization process during the forecast period.

Which segment led the lyophilization services for biopharmaceuticals market?

Based on service type, the global lyophilization services for biopharmaceuticals market is divided into commercial manufacturing, lyophilization cycle development, clinical manufacturing, and freeze-drying analytical services. The commercial manufacturing segment held the largest share of the market in 2022. The lyophilization cycle development segment is expected to grow at the highest CAGR during the forecast period.

Which end user segment held the largest revenue (US$ Mn) in the lyophilization services for biopharmaceuticals market?

Based on end user, the global lyophilization services for biopharmaceuticals market is divided into pharmaceutical and biotechnology companies, research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. The research institutes segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Lyophilization Services for Biopharmaceuticals Market

  1. ATTWILL Medical Solutions
  2. Axcellerate Pharma LLC
  3. Labyrinth Biopharma LLC
  4. Berkshire Sterile Manufacturing
  5. PCI Pharma Services
  6. Curia Global Inc
  7. Emergent BioSolutions Inc
  8. Jubilant HollisterStier LLC
  9. Biofortuna 
  10. Lyophilization Technology Inc.
  11. SYNERLAB GROUP     

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports